AKT1 and hepatocellular carcinoma: Wu S et al. found that LOXL2 expression was aberrantly expressed in liver malignancies and could enhance the infiltration and invasion of hepatocellular carcinoma cells and promote hepatocellular carcinoma metastasis through activation of the PI3K–AKT signaling pathway [35].